{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:56:53Z","timestamp":1789520213287,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001595","name":"Dystonia Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.neuroscience.2017.05.051","type":"journal-article","created":{"date-parts":[[2017,6,10]],"date-time":"2017-06-10T16:50:35Z","timestamp":1497113435000},"page":"84-98","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics"],"prefix":"10.1016","volume":"357","author":[{"given":"Melanie","family":"Hamann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagoda","family":"Plank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Smiljanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Creed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 N.","family":"Nobrega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2017.05.051_b0005","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0014-2999(92)90843-S","article-title":"Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain","volume":"217","author":"Aubert","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.expneurol.2014.08.012","article-title":"Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia","volume":"261","author":"Avchalumov","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2013.06.048","article-title":"Persistent changes of corticostriatal plasticity in dtsz mutant hamsters after age-dependent remission of dystonia","volume":"250","author":"Avchalumov","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0025","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1523\/JNEUROSCI.19-23-10237.1999","article-title":"Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation","volume":"19","author":"Bernard","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00213-007-0844-6","article-title":"The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors","volume":"194","author":"Betz","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2016.10.013","article-title":"Altered postnatal maturation of striatal GABAergic interneurons in a phenotypic animal model of dystonia","volume":"287","author":"Bode","year":"2017","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1124\/jpet.108.140350","article-title":"Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats","volume":"327","author":"Brady","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuron.2013.12.027","article-title":"Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling","volume":"81","author":"Chuhma","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfuntion as a unifying theme in the pathophysiology of dystonia","volume":"127\u2013128","author":"Eskow Jaunarajs","year":"2015","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0055","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1523\/JNEUROSCI.0466-16.2016","article-title":"Neostriatal GABAergic interneurons mediate cholinergic inhibition of spiny projection neurons","volume":"36","author":"Faust","year":"2016","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(99)01080-X","article-title":"Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters","volume":"821","author":"Gernert","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0065","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1523\/JNEUROSCI.20-18-07052.2000","article-title":"Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia","volume":"20","author":"Gernert","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(02)01546-7","article-title":"Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia","volume":"443","author":"Hamann","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nbd.2004.01.005","article-title":"Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia","volume":"16","author":"Hamann","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/01.jnen.0000178447.79713.bb","article-title":"Age-dependent alterations of striatal calretinin interneuron density in a genetic animal model of primary paroxysmal dystonia","volume":"64","author":"Hamann","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2006.04.100","article-title":"Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia","volume":"1099","author":"Hamann","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2007.02.074","article-title":"Age-related changes in parvalbumin-positive interneurons in the striatum, but not in the sensorimotor cortex in dystonic brains of the dtsz mutant hamster","volume":"1150","author":"Hamann","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0095","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.yhbeh.2007.04.006","article-title":"Acute effects of neurosteroids in a rodent model of primary paroxysmal dystonia","volume":"52","author":"Hamann","year":"2007","journal-title":"Horm Behav"},{"key":"10.1016\/j.neuroscience.2017.05.051_b9000","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1037\/0735-7044.122.1.36","article-title":"Decreased density of amygdaloid parvalbumin-positive interneurons and behavioral changes in dystonic hamsters","volume":"122","author":"Hamann","year":"2008","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0085","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jnr.21891","article-title":"Altered nicotinamide adenine dinucleotide (NADH) fluorescence in dtsz mutant hamsters reflects differences in striatal metabolism between severe and mild dystonia","volume":"87","author":"Hamann","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neuropharm.2014.09.028","article-title":"Modulation of direct pathway striatal projection neurons by muscarinic M\u2084-type receptors","volume":"89","author":"Hern\u00e1ndez-Flores","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0110","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1523\/JNEUROSCI.14-05-03351.1994","article-title":"Distribution of m1\u2013m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies","volume":"14","author":"Hersch","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0115","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S1474-4422(06)70574-9","article-title":"Treatment of dystonia","volume":"5","author":"Jankovic","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/mds.25552","article-title":"Medical treatment of dystonia","volume":"28","author":"Jankovic","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/17460441.3.1.83","article-title":"Animal models for drug discovery in dystonia","volume":"3","author":"Jinnah","year":"2008","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(03)01642-X","article-title":"Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4","volume":"468","author":"Karasawa","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2004.01.012","article-title":"Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia","volume":"16","author":"K\u00f6hling","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1523\/JNEUROSCI.22-02-00529.2002","article-title":"Dual cholinergic control of fast-spiking interneurons in the neostriatum","volume":"22","author":"Koos","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0145","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0150","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-2999(92)90229-W","article-title":"Effects of pharmacological manipulation of dopaminergic and cholinergic neurotransmission in genetically dystonic hamsters","volume":"213","author":"L\u00f6scher","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0160","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/mds.25536","article-title":"Genetics of dystonia: what's known? What's new? What's next?","volume":"28","author":"Lohmann","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1152\/jn.00269.2015","article-title":"Cholinergic mechanisms of high-frequency stimulation in entopeduncular nucleus","volume":"115","author":"Luo","year":"2016","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0170","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/brain\/awp194","article-title":"Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine","volume":"132","author":"Martella","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0175","series-title":"A stereotaxic atlas of the Golden Hamster Brain","author":"Morin","year":"2001"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0306-4522(95)00511-0","article-title":"Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster","volume":"71","author":"Nobrega","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0185","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/mds.23775","article-title":"Milestones in dystonia","volume":"26","author":"Ozelius","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1021\/cn500003z","article-title":"M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses","volume":"5","author":"Pancani","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b9005","doi-asserted-by":"crossref","first-page":"e08352","DOI":"10.7554\/eLife.08352","article-title":"Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons","volume":"4","author":"Pappas","year":"2015","journal-title":"Elife"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0195","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nbd.2009.12.003","article-title":"Convergent evidence for abnormal striatal synaptic plasticity in dystonia","volume":"37","author":"Peterson","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0200","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0891-0618(02)00066-2","article-title":"Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R, R)-I-QNB and (R, S)-I-QNB to human brain","volume":"24","author":"Piggott","year":"2002","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","article-title":"Re-emergence of striatal cholinergic interneurons in movement disorders","volume":"30","author":"Pisani","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0210","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2003.10.042","article-title":"Modulation of muscarinic facilitation of epileptiform discharges in immature rat neocortex","volume":"997","author":"Potier","year":"2004","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0215","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0306-4522(00)00073-7","article-title":"Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model","volume":"97","author":"Rehders","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0220","series-title":"Animal Models of Movement Disorders","first-page":"459","article-title":"The genetically dystonic hamster: an animal model of paroxysmal dystonia","author":"Richter","year":"2005"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0225","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/mds.870130419","article-title":"[3H]-2-Deoxyglucose uptake study in mutant dystonic hamsters: Abnormalities in discrete brain regions of the motor system","volume":"13","author":"Richter","year":"1998","journal-title":"Movement Disord"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0230","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bjp.0704268","article-title":"Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia","volume":"134","author":"Richter","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(93)90691-A","article-title":"Alterations in pharmacological sensitivity on GABAergic, but not dopaminergic and glutaminergic systems during ontogenesis in dystonic mutant hamsters","volume":"231","author":"Richter","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0240","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0301-0082(97)00089-0","article-title":"Pathophysiology of idiopathic dystonia: findings from genetic animal models","volume":"54","author":"Richter","year":"1998","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0245","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbr.2016.10.028","article-title":"Sensorimotor tests unmask a phenotype in the Dyt1 knock-in mouse model of dystonia","volume":"317","author":"Richter","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2014.07.002","article-title":"Genetic animal models of dystonia: common features and diversities","volume":"121","author":"Richter","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0255","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bjp.0706878","article-title":"Antidystonic effects of Kv7 (KCNQ) channel openers in the dtsz mutant, an animal model of hereditary paroxysmal dystonia","volume":"149","author":"Richter","year":"2006","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0260","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2990.2005.00703.x","article-title":"Age-related changes in striatal nitric oxide synthase-immunoreactive interneurones in the dystonic dtsz mutant hamster","volume":"32","author":"Sander","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.01.067","article-title":"Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant","volume":"563","author":"Sander","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1871527315666151110124136","article-title":"Lower of KV7.5 potassium channel subunit expression in an animal model of paroxysmal dystonia","volume":"15","author":"Sander","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0275","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1523\/JNEUROSCI.1381-05.2005","article-title":"Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons","volume":"25","author":"Shen","year":"2005","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.neuroscience.2017.05.051_b0280","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1124\/mol.109.056531","article-title":"A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning","volume":"76","author":"Sheffler","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0285","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejphar.2004.03.066","article-title":"Effects of anticholinergic drugs selective for muscarinic receptor subtypes on prepulse inhibition in mice","volume":"492","author":"Ukai","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.neuroscience.2017.05.051_b0290","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0295","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(83)90379-5","article-title":"Differential light microscopic autoradiographic localization of muscarinic cholinergic receptors in the brainstem and spinal cord of the rat using [3H]pirenzepine","volume":"91","author":"Yamamura","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2017.05.051_b0300","doi-asserted-by":"crossref","first-page":"9161","DOI":"10.1523\/JNEUROSCI.0873-16.2016","article-title":"Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson's disease","volume":"36","author":"Ztaou","year":"2016","journal-title":"J Neurosci"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217303858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452217303858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T10:36:52Z","timestamp":1536143812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452217303858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":62,"alternative-id":["S0306452217303858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2017.05.051","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}